Regencell Bioscience Holdings RGC
NASDAQ RGC
$10.85 +0.40 (+3.83%)
As of: Oct 21, 2026 · 12:56 PM EDT

Regencell Bioscience Holdings (RGC) Assets (2020 - 2026)

Updated

Regencell Bioscience Holdings (RGC) posted Assets of $14.73 million for the quarter ended Jun 30, 2026, up 155.9% from $5.76 million a year earlier.

Analysis

Regencell Bioscience Holdings (RGC) Assets (2020 - 2026) Analysis & Trends

Since the quarter ended Jun 30, 2020, Regencell Bioscience Holdings has reported Assets for 5 quarters.

  • Annual Assets shows a three-year compound annual growth rate of 5.3% (years ended Jun 2023 to Jun 2026).
  • In prior years, Regencell Bioscience Holdings' Assets was $5.76 million in the year ended Jun 30, 2025 and $12.62 million in the year ended Jun 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn 201.06 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn 135.12 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn 201.13 Bn
10 Regencell Bioscience Holdings 5.33 Bn 5.30 Bn - 14.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.73 Mn
Dec 31, 2025 3.01 Mn
Jun 30, 2025 5.76 Mn
Jun 30, 2024 8.44 Mn
Jun 30, 2023 12.62 Mn
Jun 30, 2022 18.02 Mn
Jun 30, 2021 340,134.00
Jun 30, 2020 514,018.00
API Access

Regencell Bioscience Holdings Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=RGC&period=max&api_key=YOUR_API_KEY